je.st
news
Generic competition, charges cut Merck Q4 profit
2013-02-01 15:00:12| Biotech - Topix.net
Merck & Co.'s fourth-quarter profit fell 7% as generic competition slashed sales of its blockbuster allergy drug Singulair and the drugmaker took sizeable restructuring and acquisition charges.
Tags: cut
charges
profit
competition
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|